Data Integration for the Assessment of Population Exposure to Ambient Air Pollution for Global Burden of Disease
Gavin Shaddick1,2, Matthew L Thomas2, Heresh Amini3,4,5
1Department of Mathematics , University of Exeter , Exeter , EX4 4QF , U.K.
Abstract:
Air pollution is a leading global disease risk factor. Tracking progress (e.g., for Sustainable Development Goals) requires accurate, spatially resolved, routinely updated exposure estimates. A Bayesian hierarchical model was developed to estimate annual average fine particle (PM2.5) concentrations at 0.1° × 0.1° spatial resolution globally for 2010-2016. The model incorporated spatially varying relationships between 6003 ground measurements from 117 countries, satellite-based estimates, and other predictors. Model coefficients indicated larger contributions from satellite-based estimates in countries with low monitor density. Within and out-of-sample cross-validation indicated improved predictions of ground measurements compared to previous (Global Burden of Disease 2013) estimates (increased within-sample R2 from 0.64 to 0.91, reduced out-of-sample, global population-weighted root mean squared error from 23 microg/m3 to 12 microg/m3). In 2016, 95% of the world's population lived in areas where ambient PM2.5 levels exceeded the World Health Organization 10 microg/m3 (annual average) guideline; 58% resided in areas above the 35 microg/m3 Interim Target-1. Global population-weighted PM2.5 concentrations were 18% higher in 2016 (51.1 microg/m3) than in 2010 (43.2 microg/m3), reflecting in particular increases in populous South Asian countries and from Saharan dust transported to West Africa. Concentrations in China were high (2016 population-weighted mean: 56.4 microg/m3) but stable during this period.
More Related Videos
Related Concept Videos
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Analysis of Population Pharmacokinetic Data
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Global Climate Change
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History


